The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Acadia Pharmaceuticals Inc shares valued at $40,133 were sold by Schneyer Mark C. on Apr 08 ’25. At $14.82 per share, Schneyer Mark C. sold 2,708 shares. The insider’s holdings dropped to 59,456 shares worth approximately $0.84 million following the completion of this transaction.
Also, Kihara James sold 1,028 shares, netting a total of over 15,235 in proceeds. Following the sale of shares at $14.82 each, the insider now holds 22,257 shares.
Before that, Kihara James had sold 1,095 shares from its account. In a trade valued at $18,670, the PRINCIPAL ACCOUNTING OFFICER traded Acadia Pharmaceuticals Inc shares for $17.05 each. Upon closing the transaction, the insider’s holdings decreased to 1,095 shares, worth approximately $0.3 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Acadia Pharmaceuticals Inc [ACAD] has been a Hold and the price target has been revised to $22. Analysts at Guggenheim downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. Earlier on August 07, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for ACAD stock which previously was a “an Overweight”.
Analyzing ACAD Stock Performance
During the last five days, there has been a drop of approximately -12.47%. Over the course of the year, Acadia Pharmaceuticals Inc shares have dropped approximately -23.11%. Shares of the company reached a 52-week high of $20.68 on 02/21/25 and a 52-week low of $13.40 on 04/09/25. A 50-day SMA is recorded $17.79, while a 200-day SMA reached $16.88.
Support And Resistance Levels for Acadia Pharmaceuticals Inc (ACAD)
According to the 24-hour chart, there is a support level at 13.51, which, if violated, would cause prices to drop to 12.92. In the upper region, resistance lies at 14.73. The next price resistance is at 15.36. RSI (Relative Strength Index) is 29.19 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.64, which suggests the price will decrease in the coming days. Percent R is at 82.68%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
